Cardiovascular disease risk prediction in the UK: Which is the best risk prediction model?

Primary Care Cardiovascular Journal

Volumn 6, Issue 3, 2013, Pages 125-128

  Collins, Gary S ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CALIBRATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; FEMALE; FRAMINGHAM RISK SCORE; HUMAN; INTERMETHOD COMPARISON; LIFESTYLE; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; MIDDLE AGED; PERFORMANCE; PREDICTION; PREDICTIVE VALUE; QRISK SCORE; QRISK2 SCORE; UNITED KINGDOM; VERY ELDERLY;

EID: 84893443885     PISSN: 17565138     EISSN: 17565146     Source Type: Journal    
DOI: 10.3132/pccj.2013.011     Document Type: Article

References (25)

1. Cooney MT, Cooney HC, Dudina A et al. Total cardiovascular disease risk assessment: a review. Curr Opin Cardiol 2011;26:429-37.
2. Cooney MT, Dudina AL, Graham IM. Value and limitations of existing scores for the assessment of cardiovascular risk: a review for clinicians. J Am Coll Cardiol 2009; 54:1209-27.
3. Mayor S. Doctors no longer have to use Framingham equation to assess heart disease risk, NICE says. BMJ 2010;340:c1774.
4. Anderson KM, Odell PM, Wilson PWF et al. Cardiovascular disease risk profiles. Am Heart J 1991;121:293-8.
5. Woodward M, Brindle P, Tunstall-Pedoe H. Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC). Heart 2007;93:172-6. (Pubitemid 46180289)
6. Hippisley-Cox J, Coupland C, Robson J et al. Advantages of QRISK2 (2010): the key issue is ethnicity and extent of reallocation. Heart 2011;97:515.
7. Hippisley-Cox J, Coupland C, Vinogradova Y et al. Performance of the QRISK cardiovascular risk prediction algorithm in an independent UK sample of patients from general practice: a validation study. Heart 2008;94:34-9.
8. Hippisley-Cox J, Coupland C, Vinogradova Y et al. Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2. BMJ 2008;336:1475-82. (Pubitemid 351977019)
9. Hippisley-Cox J, Coupland C, Vinogradova Y et al. Derivation and validation of QRISK, a new cardiovascular disease risk score for the United Kingdom: prospective open cohort study. BMJ 2007;335:136.
10. Siontis GC, Tzoulaki I, Siontis KC et al. Comparisons of established risk prediction models for cardiovascular disease: systematic review. BMJ 2012;344:e3318.
11. Collins GS, Altman DG. Predicting the 10 year risk of cardiovascular disease in the United Kingdom: independent and external validation of an updated version of QRISK2. BMJ 2012;344:e4181.
12. White IR, Royston P, Wood AM. Multiple imputation using chained equations: Issues and guidance for practice. Stat Med 2011;30:377-99.
13. Rubin DB. Multiple Imputation for Nonresponse in Surveys. New York: Wiley & Sons, 1987.
14. Steyerberg EW. Clinical prediction models: a practical approach to development, validation, and updating. New York: Springer, 2008.
15. Royston P. Explained variation for survival models. Stats J 2006;6(1):83-96. (Pubitemid 43708445)
16. Royston P, Sauerbrei W. A new measure of prognostic separation in survival data. Statistics Medicine 2004; 23:723-48. (Pubitemid 38279510)
17. Vickers AJ, Elkin EB. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making 2006;26:565-74. (Pubitemid 44728772)
18. Collins GS, Altman DG. An independent external validation and evaluation of QRISK cardiovascular risk prediction: a prospective open cohort study. BMJ 2009; 339:b2584.
19. Collins GS, Altman DG. An independent and external validation of QRISK2 cardiovascular disease risk score: a prospective open cohort study. BMJ 2010;340:c2442.
20. Sterne JAC, White IR, Carlin JB et al. Multiple imputation for missing data in epidemiological and clinical research: potential and pitfalls. BMJ 2009;338(jun29 1):b2393-b93 doi: 10.1136/bmj.b2393[published Online First: Epub Date].
21. de la Iglesia B, Potter JF, Poulter NR et al. Performance of the ASSIGN cardiovascular disease risk score on a UK cohort of patients from general practice. Heart 2011; 97:491-9.
22. Collins GS, Altman DG. Report to the Department of Health: independent validation of QRISK on the THIN database: University of Oxford, 2008.
23. Durrington P. How to estimate cardiovascular risk in practice. Prim Care Cardiovasc J 2009;2:175-80.
24. Tunstall-Pedoe H. Cardiovascular risk and risk scores: ASSIGN, Framingham, QRISK and others: how to choose. Heart 2011;97:442-4.
25. Collins GS, Moons KGM. Comparing risk prediction models. BMJ 2012;344:e3186.